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Abstract
Background: Duplication of chromosome 15q11-q13 (dup15q) accounts for approximately 3% of autism cases.
Chromosome 15q11-q13 contains imprinted genes necessary for normal mammalian neurodevelopment controlled
by a differentially methylated imprinting center (imprinting center of the Prader-Willi locus, PWS-IC). Maternal
dup15q occurs as both interstitial duplications and isodicentric chromosome 15. Overexpression of the maternally
expressed gene UBE3A is predicted to be the primary cause of the autistic features associated with dup15q.
Previous analysis of two postmortem dup15q frontal cortical samples showed heterogeneity between the two
cases, with one showing levels of the GABAA receptor genes, UBE3A and SNRPN in a manner not predicted by
copy number or parental imprint.
Methods: Postmortem human brain tissue (Brodmann area 19, extrastriate visual cortex) was obtained from 8
dup15q, 10 idiopathic autism and 21 typical control tissue samples. Quantitative PCR was used to confirm
duplication status. Quantitative RT-PCR and Western blot analyses were performed to measure 15q11-q13 transcript
and protein levels, respectively. Methylation-sensitive high-resolution melting-curve analysis was performed on
brain genomic DNA to identify the maternal:paternal ratio of methylation at PWS-IC.
Results: Dup15q brain samples showed a higher level of PWS-IC methylation than control or autism samples,
indicating that dup15q was maternal in origin. UBE3A transcript and protein levels were significantly higher than
control and autism in dup15q, as expected, although levels were variable and lower than expected based on copy
number in some samples. In contrast, this increase in copy number did not result in consistently increased GABRB3
transcript or protein levels for dup15q samples. Furthermore, SNRPN was expected to be unchanged in expression
in dup15q because it is expressed from the single unmethylated paternal allele, yet SNRPN levels were significantly
reduced in dup15q samples compared to controls. PWS-IC methylation positively correlated with UBE3A and
GABRB3 levels but negatively correlated with SNRPN levels. Idiopathic autism samples exhibited significantly lower
GABRB3 and significantly more variable SNRPN levels compared to controls.
Conclusions: Although these results show that increased UBE3A/UBE3A is a consistent feature of dup15q
syndrome, they also suggest that gene expression within 15q11-q13 is not based entirely on copy number but can
be influenced by epigenetic mechanisms in brain.
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Autism is a common neurodevelopmental disorder
affecting 1 in 110 children [1], but its genetic etiology is
complex and heterogeneous [2,3] Among the leading
genetic causes of autism are abnormalities in proximal
chromosome 15q, collectively referred to as “duplication
15 syndrome” (dup15q), which occur in ~1-3% of aut-
ism cases [4-6]. Dup15q syndrome is a clinically hetero-
geneous neurodevelopmental disorder characterized by
varying degrees of cognitive impairment, gross motor
delays, seizures, dysmorphic features and autism in 85%
of cases [5,7,8].
Chromosome 15q11-q13 is a genetic hotbed for neuro-
developmental disorders because of a high density of low
copy repeats (LCRs) that increase susceptibility to errors
in meiotic recombination, resulting in deletions as well as
duplications [9,10]. The parental origin of deletions and
duplications influences the expression of 15q11-q13
through genomic imprinting. Imprinting of 15q11-q13 is
regulated by the bipartite imprinting center (IC), which
contains a differentially methylated region at the 5’ end
of SNRPN that controls expression throughout 15q11-
q13 [11]. Loss of 15q11-q13 paternally expressed genes
through deletions or maternal uniparental disomy (UPD)
results in Prader-Willi syndrome (PWS), whereas the
maternal deficiency at this locus results in a phenotypi-
cally distinct neurodevelopmental disorder, Angelman
syndrome (AS).
Maternally derived duplications of chromosome 15,
specifically 15q11-q13, are associated with an autistic
phenotype, whereas paternally derived duplications pri-
marily show normal phenotypes but may manifest neuro-
logical features other than autism [7,12]. In addition,
individuals with PWS with maternal UPD show a higher
occurrence of autism compared to those with PWS
15q11-q13 deletions [13,14], suggesting that overexpres-
sion at maternally expressed genes confers risk for autism
[13,15]. The E3 ubiquitin ligase gene (UBE3A) is the only
known paternally imprinted gene in the locus, and its
maternal allele-specific transcription is limited to postna-
tal neurons [16,17]. While ATP10A was previously
described as maternally expressed [18,19], recent studies
have shown variable imprinting in humans and lack of
imprinting in mouse [20,21]. Paternally expressed genes
within 15q11-q13 include the splicing factor encoding
SNRPN, necdin (NDN), MAGEL2 and several large clus-
ters of small nucleolar RNAs (snoRNAs). A cluster of
three receptor subunit genes for the neurotransmitter
GABAA (GABRB3, GABRA5, GABRG3) are biallelically
expressed in control brain tissue samples, but show epi-
genetic alterations that result in monoallelic expression
in a subset of autism cortical samples [22].
Although increased copy number is generally
assumed to increase transcript levels, the epigenetic
and neurodevelopmental complexities associated with
15q11-q13 confound this simple explanation of UBE3A
overexpression as the sole molecular cause of the
dup15q phenotype. In addition to imprinting, the
15q11-q13 locus is subject to the interchromosomal
higher organization of homologous pairing between
maternal and paternal alleles [23-25]. Chromosome 15
duplications result in disrupted homologous pairing in
dup15q brain tissue samples [26] and a neuronal cell
line model of dup15q [24]. In addition, disruption of
15q11-q13 pairing by dup15q in neurons has been
shown to result in reduced transcript levels of NDN,
SNRPN, GABRB3 and CHRNA7 [24]. In a prior analy-
sis of two dup15q cortical tissue samples, one showed
reduced levels of the paternally derived transcripts
SNRPN,s n o R N A s ,NDN and the biallelically expressed
GABRB3, GABRA5 and GABRG3 transcripts that cor-
responded to PWS-like behaviors [26].
To further understand the genetic and epigenetic effects
on transcript levels that lead to the pathogenesis of
dup15q syndrome, we performed an extensive analysis of
a panel of eight dup15q cortical tissue samples as com-
pared to control and idiopathic autism samples. The
dup15q samples showed changes in both methylation and
transcription levels, with UBE3A showing significantly
higher, SNRPN showing significantly lower and GABRB3
showing variable transcript levels as compared to controls.
Interestingly, UBE3A transcript positively correlated with
maternal allele-specific methylation of the Prader-Willi
imprinting control locus (PWS-IC) within the dup15q
samples. These results support the hypothesis that ele-
vated UBE3A levels in the brain are a major contributor to
the dup15q phenotype but also are consistent with obser-
vations that dup15q syndrome results in transcriptional
and epigenetic changes that are variable and not based
solely on copy number.
Methods
RNA extraction and cDNA synthesis
Frozen cerebral cortex samples from Brodmann area 19
(BA19) were obtained through the Autism Tissue Pro-
gram from the University of Maryland Brain and Tissue
Bank for Neurodevelopmental Disorders, the Harvard
Brain and Tissue Resource Center and the University of
Miami Brain and Tissue Bank for Neurodevelopmental
Disorders. Brain tissues were stored at -80°C until pro-
cessing. While the tissues were kept frozen on dry ice,
0.1 to 0.15 g was sliced and homogenized using TRIzol
reagent (Invitrogen/Life Technologies, Carlsbad, CA,
USA). All RNA work was done on a bench using pipettes
wiped down with Ambion RNaseZap wipes (Invitrogen/
Life Technologies, Austin, TX, USA) prior to beginning
work to prevent RNase contamination of the sample. To
eliminate DNA contamination, the RNA was treated with
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according to the manufacturer’s instructions and precipi-
tated using sodium acetate and ethanol. Single-stranded
cDNA was synthesized using QuantiTect Reverse Tran-
scription Kit (QIAGEN, Valencia, CA, USA) and incu-
bated for 15 minutes at 42°C followed by 15 minutes at
50°C with a 3-minute deactivation step at 95°C. For each
reaction, a tube without RT was used as a control for
genomic DNA contamination. After completion, each
reaction was diluted 4.75-fold with DNase- and RNase-
free water.
Quantitative RT-PCR
Primers were designed using mRNA sequences extracted
from the UCSC Genome Browser [27] with the February
2009 human reference sequence (GRCh37). Primers
w e r ed e s i g n e dt oc r o s sa ni n t r o no rs p a ni n t r o n - e x o n
boundaries to limit genomic DNA contamination using
Primer3 software [28] or Biosearch Technologies RealTi-
meDesign software (Biosearch Technologies Inc, Novato,
C A ,U S A ;h t t p : / / w w w . b i o s e a r chtech.com/realtimede-
sign). These primer sequences are shown in Additional
file 1. Each reaction was carried out in triplicate, and
outliers were removed according to the method
described by Bookout et al. [29]. PCR amplification of
cDNA was performed using 200 nM primers and
EXPRESS SYBR GreenER Universal Master Mix (Invi-
trogen/Life Technologies). Cycling conditions were 20
seconds at 95°C followed by 40 cycles of 2 seconds at
95°C and 30 seconds at 60°C. The reaction was per-
formed using the Mastercycler ep realplex real-time
PCR system (Eppendorf, Hamburg, Germany), and
crossing points were analyzed using Realplex software.
For each reaction, we ran a well of no RT and no cDNA
control to evaluate genomic DNA contamination, non-
specific product formation or other contamination.
Reaction conditions were as follows: 1× EXPRESS SYBR
GreenER Universal Master Mix, 200 nM primers and
3.5 μl of cDNA. Cycling conditions were as follows: All
samples were normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) using the comparative cycle
threshold (CT) method (Applied Biosystems, Foster City,
CA, USA) to measure fold changes relative to the cali-
brator, following normalization to GAPDH.M e l t i n g
curve analysis was also performed to determine homo-
geneous product formation with no primer-dimers and
no nonspecific products.
Quantitative PCR for copy number analysis
Genomic DNA was isolated from brain tissue samples
by using the Gentra Puregene Tissue Kit (QIAGEN).
PCR conditions were the same as described above using
primers shown in Additional file 1.
Determination of methylation percentage at the
imprinting center
Methylation-sensitive high-resolution melting-curve ana-
lysis (MS-HRM) was performed as described by Urraca
et al. [30]. Briefly, 500 ng of DNA was treated with
bisulfite. The treated sample (50 ng) was then used for
MS-HRM on the LightCycler 480 Real-Time PCR Sys-
tem (Roche Applied Science, Indianapolis, IN, USA)
using primers and conditions previously described [30].
Since the paternal SNRPN IC allele is completely
unmethylated and the maternal allele is methylated, the
normalized fluorescence intensity reveals the percentage
of methylated (maternal) to unmethylated (paternal)
allele present in a given sample. Additional copies of a
maternal duplication of this region results in a higher
percentage of maternal allele-specific (methylated) fluor-
escent signal.
Protein level analyses
Protein extracts were isolated from the same frozen brain
tissue samples using TRIzol reagent and analyzed for
UBE3A and GABRB3 levels as described previously [31].
Results
Quantitative determination of genomic copy number and
PWS-IC methylation in human brain samples
To understand the relationship between increased mater-
nal copy number of chromosome 15 and transcript levels
in brain, frozen postmortem brain tissue samples from
eight dup15q syndrome, twenty-one control and ten idio-
pathic autism human cortex tissue samples were
obtained from BA19. Figure 1 documents the age, gender
and expected 15q copy number extracted from Autism
Tissue Program records. The chromosome 15 duplica-
tion and expected copy number were confirmed by quan-
titative PCR (qPCR) performed on genomic DNA from
brain tissue samples at three loci (SNRPN, UBE3A and
GABRB3) compared to an unduplicated control locus,
B2M. Figure 2 shows the expected copy number and par-
ental expression patterns of the three subtypes of dup15q
in the collection of brain samples. Six of the dup15q sam-
ples showed twofold (2.10 ± 0.14, mean ± SEM) higher
levels of 15q loci compared to control samples as
expected for typical isodicentric 15q (idic15) duplications
(Figure 2b). Case 6294 was confirmed as an interstitial
15q11-q13 duplication (int dup(15)) with 1.5-fold higher
copy number as compared to controls with a total of
three copies to each control’s two (Figure 2c). Case 7014
has been described previously by both fluorescence in
situ hybridization and array-comparative genomic hybri-
dization as having a tricentric derivative of chromosome
15 [32], and qPCR confirmed a threefold excess of the
three loci compared to controls (Figures 1 and 2d).
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common in autism cases, paternally derived duplications
may also lead to phenotypic effects, including, but not
exclusive to, autism [4]. Therefore, to verify the parental
origin of the chromosome 15 duplication in each sample,
analysis of the methylation status of the PWS-IC was per-
formed by MS-HRM on the PCR product of bisulfite-
converted DNA [30]. This method quantitates the per-
centage maternal vs paternal (that is, methylated DNA vs
unmethylated DNA) at the PWS-IC. The ratio of
methylated to unmethylated alleles is a clear indicator of
the parental origin of the duplication because a higher
methylated fluorescent signal means that more maternal
(methylated) DNA than paternal DNA (unmethylated) is
present, with the caveat that the 15q duplications have
no IC defects, which could result in incomplete or inap-
propriate methylation of the SNRPN locus [30]. The ratio
of maternal to paternal chromosomal copies (M:P) can
be calculated by this method, given that the paternal
PWS-IC is always unmethylated and the maternal PWS-
Figure 1 Characteristics of individual postmortem human cortex tissue samples and experimental outcomes. Age and gender are listed
with the sample number (M, male; F, female). The expected genetic ratio is the number of maternal copies of 15q11-q13 to paternal copies (M:
P). The percentage maternal allele-specific methylation in the fluorescent signal for both maternal and paternal melting peaks at the imprinting
center of the Prader-Willi locus by methylation-sensitive high-resolution melting-curve analysis is shown in column 5 and then converted to a M:
P ratio in column 6. Column 7 shows the M:P methylation ratio after normalization to control brain, with the average control (CTRL) set to 1.0.
Columns 8 to 10 show the individual transcript levels normalized to CTRL brain. Protein levels are listed in columns 11 and 12. Each individual
transcript and protein level was compared to the expected number of expressed copies relative to unaffected CTRL brain tissues. The data in
columns 7 to 12 were then color-coded with a heat map used to visualize the fold changes as higher or lower than expected based on copy
number and parental origin. Red is higher than and purple is lower than expected by copy number, with each intensity increase giving a 20%
increase or decrease, respectively. *Case 7041 came from an individual who was on a respirator just prior to sample collection.
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(reviewed in [30]). Unexpectedly, this method revealed
higher methylation levels in brain compared to blood
samples that we previously analyzed at this locus, with an
average of 61.7% (1.6:1 M:P ratio) in control brain com-
pared to 52% previously observed in blood [30]. Brain tis-
sue samples from idiopathic autism subjects exhibited
methylation ratios similar to controls, with 61.3% methy-
lation and a M:P ratio of 1.6:1. The observed methylation
ratios were then “brain-normalized” to the average con-
trol maternal methylation percentage to give an average
1:1 M:P ratio for controls, which adjusted the average
dup15q M:P ratio to 2.9:1 (Figure 1, column 7). Both
observed and normalized methylation ratios were higher
in all eight chromosome 15 duplication samples, con-
firming the maternal origin of the additional 15q alleles
(Figure 3). There was some variation in the percentage
methylation in the 3:1 expected ratio class, but this type
of variation was also observed in the 2:1 ratio int dup(15)
blood samples [30].
Quantitation of UBE3A, SNRPN and GABRB3 transcript
levels
To determine the effect dup15q and PWS-IC methylation
may have on the transcript levels of the genes within this
duplicated region, qRT-PCR was performed on RNA
samples isolated from each brain tissue sample. Three
chromosome 15 transcripts were amplified, including
maternally expressed UBE3A, paternally expressed
SNRPN and biallelically expressed GABRB3 (shown in
Figure 2). The results were normalized to the chromo-
some 12 housekeeping control gene GAPDH by using the
comparative CT method. The transcript levels, described
as fold changes from average control, are shown for each
b r a i nt i s s u es a m p l ei nF i g u r e1 ,c o l u m n s8t o1 0 .T o
visualize the direction and level of change from the
Figure 2 Diagrams of chromosome 15q11-q13 gene order and expected expression patterns in duplication of 15q11-q13 (dup15q)
and control samples based on copy number and parental origin. The paternal chromosome is shown in blue and the maternal
chromosome in red. Genes are listed and color blocks match, respectively, to model the location on the chromosome with the orientation
indicated by arrows. Red × marks represent silencing from parental imprinting. The table at the top lists total genomic copies and the number
of copies of each gene and color code: small nucleoriboprotein N (SNRPN), green; ubiquitin ligase 3A (UBE3A), yellow; and GABAA receptor b3
(GABRB3), purple. (a) Control (CTRL), (b) interstitial duplication of 15q (int dup(15q)) has one additional copy, (c) isodicentric duplication of
chromosome 15 (idic(15q)) has two additional maternal copies of the locus and (d) the tricentric supernumerary chromosome 15, which
contains four additional copies of chromosome 15.
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number at the 15q locus. (a) Example of methylation-sensitive high-resolution melting-curve analysis showing > 80% methylated PWS-IC for
duplication of 15q11-q13 (dup15q) sample 7041 (3:1 expected genetic ratio of the number of maternal copies of 15q11-q13 to paternal copies
(M:P)) and sample 7014 (5:1 expected M:P ratio) (blue curves). All control and autism samples showed, on average, a 62% methylated PWS-IC
(sample 6184 autism (orange) and sample 1649 control (green) here). The Prader-Willi syndrome uniparental disomy (PWS-UPD) (yellow) and the
Angelman syndrome (AS) deletion (dark red) are shown as indicators of completely unmethylated (AS del) or completely methylated (PWS-UPD)
signals from the PWS-IC. The blue arrows show the determination of percentage methylation from the percentage relative signal y-axis. (b) This
graph presents the normalized methylation ratio (M:P) shown in Figure 1 grouped by genotype. Note that both control and autism samples
cluster tightly at the 1:1 ratio in all samples. There was a single interstitial duplication sample (predicted 2:1 ratio) and a single complex
isodicentric 15q (idic15) duplication sample (predicted 5:1 ratio), though the majority of cases examined were idic15q with four copies of the
locus (predicted 3:1 ratio). Although somewhat variable, the mean ratio for the Dup 3:1 samples was approximately 3:1 and significantly different
from both controls (P = 0.0037) and autism cases (P = 0.0035) by t-test using Welch’s correction. The individual Dup 2:1 and Dup 5:1 samples
showed higher and lower than predicted ratios, respectively. Error bars represent SEM. There was a positive correlation between the percentage
methylation of the PWS-IC and the number of copies of the 15q region, which contains the PWS-IC, on the basis of simple regression analysis (P
< 0.001).
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were utilized, in which red is higher, purple is lower and
white is < 20% change from expected.
The imprinted gene UBE3A is expressed from the
maternally derived duplication in addition to the nor-
mally inherited maternal chromosome. Idic15, int dup15
and the tricentric duplication would be expected to show
3×, 2× and 5× the number of expressed copies compared
to both control and idiopathic autism, respectively (Fig-
ure 2). UBE3A transcript was significantly increased in
dup15q samples compared to both the control group and
autism (P = 0.004 and P = 0.045, respectively) (Figure
4a). In addition, the variability in UBE3A transcript levels
between individual dup15q samples was significantly
greater than in control or idiopathic autism samples (P =
0.002 and P = 0.045, respectively; Levene’s test for equal-
ity of variances) (Figures 4a and 4d). When only samples
with the same copy number (M:P ratio 3:1) were ana-
lyzed, UBE3A levels were an average twofold higher
rather than the expected threefold (Additional file 2).
When analyzed individually, five of the dup15q samples
exhibited UBE3A levels higher than controls, whereas the
other three dup15q samples showed levels similar to the
control samples (Figure 4d). One idic15 sample (sample
7436) showed UBE3A transcript levels equivalent to the
number of maternal copies (three) of UBE3A (Figure 1,
column 8, and Figure 4d). However, the level of expres-
sion did not linearly correlate with the number of copies
of the maternal allele present, with most dup15q samples
showing lower UBE3A levels than expected (Figures 1
and 4d). These results indicate that elevated UBE3A
levels are present in the brains of dup15q individuals, but
that the levels are variable and generally lower than
expected.
Figure 4 Transcript level analyses of ubiquitin ligase 3A (UBE3A), GABAA receptor b3( GABRB3) and small nucleoriboprotein N (SNRPN)
in postmortem human brain tissue. (a) through (c) box-and-whisker plots diagramming transcript levels in postmortem human brain
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (a) UBE3A showed a significant increase in mean values for duplication of
15q11-q13 (dup15q) compared to control (CTRL) and autism (AUT). (b) GABRB3 was lower in AUT than in CTRL, whereas dup15q samples
showed a significantly increased variance compared with both AUT and CTRL. (c) SNRPN expression levels were significantly lower in dup15q
than in the other groups. In addition, AUT showed significantly increased variance for SNRPN levels compared to CTRL and dup15q. Significant
differences are indicated by *P < 0.05, **P < 0.01 and ***P < 0.001. Significant differences in the variance between groups were determined by
Levene’s test for equality of variances, which are represented in blue. Black represents significant differences in the group means as determined
by t-test. (d) through (f) Histograms representing the distribution of transcript levels in individual postmortem human brain grouped by
condition are shown.
Scoles et al. Molecular Autism 2011, 2:19
http://www.molecularautism.com/content/2/1/19
Page 7 of 14GABRB3 is biallelically expressed, so the idic15, int
dup(15) and tricentric derivative chromosome M:P
ratios were expected to be 2:1, 1.5:1 and 3:1, respec-
tively, compared to control samples (Figure 2). GABRB3
levels in the dup15q cortex samples instead were highly
variable, as three samples showed 0.3× lower expression
and five samples showed 1.5× higher GABRB3 levels
compared with typically developing controls (Figures 1,
4b and 4e). Figure 4b shows that the biallelically
expressed GABRB3 exhibited no significant changes in
the quantity of transcript in dup15q samples as a group;
h o w e v e r ,t h ev a r i a n c ei nGABRB3 was significantly dif-
ferent from both the control group (P < 0.001) and the
autism group (P < 0.001; t-test). Figure 4e of the distri-
bution of GABRB3 levels shows two groups of dup15q
samples clustered as either higher or lower than control
samples. The idiopathic autism group showed a signifi-
cant reduction in GABRB3 transcript compared with
controls as reported previously [22].
SNRPN is paternally expressed and in all cases has one
expressed copy, because all of the chromosome 15 dupli-
cations used were maternally derived. Surprisingly similar
to an idic15 brain sample we previously reported from an
individual with PWS-like features [26]. SNRPN was lower
than expected by at least 0.77× in six of eight dup15q
samples (Figures 1 and 4f) and significantly lower in
dup15q samples compared to control or autism samples
(Figure 4c). SNRPN levels were reduced from control in
sample 6856 and increased from control in sample 7436,
similar to findings of the previous study of BA9 prefron-
tal cortex [26]. Idiopathic autism showed no significant
change in SNRPN level, but did show an increase in
variability of the ten samples compared to control (P =
0.006; Levene’s test for equality of variances) and to
dup15q (P = 0.045; Levene’st e s tf o re q u a l i t yo f
variances).
Correlation analyses of 15q transcript and protein levels
with copy number and maternal PWS-IC methylation
As UBE3A, GABRB3 and SNRPN were expressed at lower
levels than predicted by copy number and parental origin
in dup15q brain, we sought to determine whether the
transcript levels for genes within the dup15q locus corre-
late with the number of gene copies. UBE3A and
GABRB3 would both be expected to show a positive cor-
relation with the number of gene copies, because the
duplication is maternally derived. A significant positive
correlation in GABRB3 and UBE3A transcript levels was
observed with increased chromosomal copies when all
cases (control, autism and dup15q) were analyzed as a
group (Figures 5a and 5b). This finding was not signifi-
cant for the dup15q cases analyzed separately, although
the positive trend was apparent (Additional file 3).
SNRPN is paternally expressed and was therefore
expected to show no correlation with the number of
maternal copies of 15q; however, it showed a significant
negative correlation of transcript with copy number for
all cases (Figure 5c), but the correlation was not signifi-
cant in the individually analyzed dup15q group (Addi-
tional file 3).
As expected on the basis of the maternal origin of the
duplication, 15q11-q13 copy number correlated signifi-
cantly with percentage PWS-IC methylation (Figure 3).
UBE3A transcript level was significantly correlated with
increased PWS-IC methylation for all samples (Figure 6a)
and for the dup15q samples grouped separately (Figure 6b).
When the control and autism cases were analyzed sepa-
rately, however, no significant correlation between PWS-IC
Figure 5 Correlation analyses of 15q11-q13 copy number and transcript levels. The relationship between the number of genomic copies
of 15q11-q13 and transcript levels in all cases showed a predictive positive correlation with GABAA receptor b3( GABRB3) (a) and ubiquitin ligase
3A (UBE3A) (b), but a negative correlation with small nucleoriboprotein N (SNRPN) (c). Significance was calculated by simple regression analysis.
Diamond, duplication of 15q11-q13; triangle, autism; square, control.
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GABRB3 also significantly positively correlated with per-
centage PWS-IC methylation for all cases (Figure 6c).
Unlike UBE3A, though, there was no significant correlation
with percentage methylation in the dup15q cases grouped
separately or with the control or autism cases alone (Addi-
tional file 5). In contrast to both UBE3A and GABRB3,
SNRPN levels were significantly negatively correlated with
percentage PWS-IC methylation in all cases (Figure 6d) but
not with dup15q, control or autism cases analyzed sepa-
rately (Additional file 6).
Protein was isolated from the same tissue as RNA and
DNA from each brain sample to determine whether pro-
tein levels of 15q transcripts were significantly different
between brain sample types or correlated with other mea-
surements. Western blot analyses are only semiquantita-
tive, thus, compared with qRT-PCR, we observed a larger
variability between control samples (P = 0.02; Levene’st e s t
for equality of variances). Similarly to the transcript ana-
lyses, a significantly higher protein level of UBE3A was
observed between control and dup15q (Figure 7a), but
GABRB3 protein showed no significant differences
Figure 6 Ubiquitin ligase 3A (UBE3A) and GABAA receptor b3( GABRB3) levels positively correlate with imprinting center of the Prader-
Willi locus (PWS-IC) methylation while small nucleoriboprotein N (SNRPN) levels negatively correlate with PWS-IC methylation.A
significant positive correlation between PWS-IC methylation and UBE3A transcript levels was observed when all cases were grouped together (a)
or for duplication of 15q11-q13 (dup15q) samples only (b). There was no significant correlation between percentage maternal allele-specific
methylation at the PWS-IC and levels of UBE3A when cases were grouped separately without duplications as control or autism (Additional file 4).
The percentage methylation of PWS-IC correlated with an increase in GABRB3 in all cases (c). When separated by diagnosis, however, the positive
trend between GABRB3 and PWS-IC methylation in dup15q, control, or autism cases analyzed separately did not reach significance (Additional
file 5). A significant negative correlation between SNRPN and PWS-IC methylation was observed for all cases (d); however, no significant
correlation was observed for dup15q, control, or autism samples grouped separately for comparison of SNRPN and PWS-IC methylation
(Additional file 6). Significance was calculated by a simple regression analysis. Diamond, dup15q; triangle, autism; square, control.
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7b). No differences in variability within groups were
observed at the GABRB3 protein level (Additional file 7),
unlike our observations of GABRB3 transcript levels. At
the protein level, both UBE3A and GABRB3 showed no
significant relationship with copy number (Additional file
8) or percentage methylation of the PWS-IC (Additional
files 9 and 10). The results therefore show that increased
expression of both UBE3A transcript and UBE3A protein
is a consistent feature of dup15q cortex.
Discussion
This paper reports the largest study of dup15q brain
samples to date. Our results demonstrate that duplication
of the 15q11-q13 region alters the expression not only of
UBE3A, as expected, but also the expression of SNRPN
and GABRB3 in ways not always predicted by copy num-
ber, confirming our prior small-scale study [26]. Pre-
viously, UBE3A overexpression from the duplicated
maternal allele had been hypothesized to be the sole
explanation for autism comorbidity in dup15q syndrome
as well as the increase in autism spectrum disorder
(ASD) phenotypes in PWS maternal UPD compared to
deletion cases [13,33]. It is important to keep in mind
that the PWS-IC is methylated on all maternal alleles,
regardless of allele copy number [34]. Even in studies of
various nonneuronal cell lines, however, where UBE3A is
expressed biallelically, increases in UBE3A transcript in
Figure 7 Analysis of ubiquitin ligase 3A (UBE3A) and GABAA receptor b3 (GABRB3) protein levels in postmortem human brain
samples. Box-and-whisker plots diagramming protein levels in postmortem human brain tissue normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) by Western blot analysis with a significant increase of UBE3A protein level in duplication of 15q11-q13 (dup15q) (a)
and no significant change in GABRB3 protein levels (b). Significant differences are indicated by *P < 0.05 and **P < 0.01. Significant differences
in the group means were determined by t-test. Distribution histograms of protein levels of individual brain tissue samples are shown in
Additional file 7.
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cates the prior findings of increased UBE3A levels in
human cortex, showing a twofold increase in dup15q
samples. In contrast, GABRB3 expression was not ana-
lyzed in any of the prior studies in cell lines, because
GABRB3 is a neuronally expressed gene. SNRPN is
expressed in nonneuronal cell lines, but researchers in
prior studies did not find SNRPN levels to be different
from those of controls in nonneuronal cells [34-36]. In
our investigation of dup15q human cortex samples, how-
ever, SNRPN levels were significantly lower than in con-
trols, a result that we did not expect, since all of the
samples (control, autism and dup15) should express one
copy of the SNRPN gene from the single paternal allele
present. Our results therefore demonstrate the tissue-
specific epigenetic complexities associated with dup15q
syndrome in humans which simple copy number changes
are inadequate to explain.
Epigenetic patterns and mechanisms are often tissue-
specific, and the brain shows high levels of DNA methy-
lation despite being primarily nonmitotic in postnatal
life [37]. Our recent genomic analysis of DNA methyla-
tion showed large genomic regions that are highly
methylated in neurons compared to fibroblasts that span
large regions of 15q11-q13 [38]. Interestingly, in this
study, we observed tissue-specific differences in PWS-IC
methylation between brain tissues as compared to blood
samples analyzed previously [30] by MS-HRM, with
brain tissue showing a higher percentage of baseline
maternal allele-specific methylation in controls. The
MS-HRM analysis of the PWS-IC upstream of SNRPN
showed that, when normalized to brain, a M:P methyla-
tion ratio of 2.9:1 was observed, indicating that the
duplications are maternal in origin. The increased
methylation observed in dup15q samples is consistent
with findings of previous studies in blood from int dup
(15) samples showing that the duplication is maternal,
not paternal, in origin. However, it is possible that the
paternal allele may be methylated at one or more indivi-
dual bases in the dup15q samples only. The recent dis-
covery of 5-hydroxymethylcytosine (5-hmC) [39,40] may
be of significance in this regard, because more 5-hmC
has been found in brain than in other tissues [41] and
5-hmC is thought to affect gene regulation through
DNA demethylation [42] or by converting 5-methylcyto-
sine (5-mC) to 5-hmC [43-45]. Further investigation of
the methylation status of the PWS-IC in brain samples
is needed to determine whether the bisulfite-converted
sites are protected by 5-hmC or 5-mC.
UBE3A transcript and protein levels were increased
twofold on average in dup15q samples compared to
controls in our study, consistent with the hypothesis
that there is increased maternal allele-specific expression
of UBE3A in dup15q autism brain. These levels were
slightly lower than expectedf r o mm a t e r n a l l ye x p r e s s e d
genes with an average of three maternal alleles, but this
may reflect the complex transcriptional and posttransla-
tional regulation of UBE3A. The function of UBE3A as
a transcriptional coactivator has been largely unexplored
in the context of human genetic disease, but, in a Droso-
phila model of 15q duplication syndrome, elevated
levels of an enzymatically defective version of Dube3a
were able to induce transcription of the dopamine regu-
lator GTP cyclohydrolase I and elevate dopamine levels
in the fly brain [46]. UBE3A can trans-ubiquitinate itself
in vivo, leading to self-degradation, supporting the idea
that there is an upper limit for UBE3A protein induc-
tion that may be reached in as few as two active copies
of the duplicated region.
Dup15q sample 6,856 showed a 2.5-fold increase in
UBE3A compared to no significant change as seen pre-
viously for a different brain region from this individual
[26]. Brain region differences in transcript levels within
the same individual may explain some of the clinical
heterogeneity seen within the dup15q syndrome. They
may also potentially be explained by the stochastic nat-
ure of the epigenetic dysregulation. Interestingly, the
epigenetic measure that best correlated with UBE3A
levels in the dup15q brain samples was the level of
PWS-IC methylation. Since the correlation was positive
rather than negative, we hypothesize that maternal
PWS-IC methylation acts as a long-range enhancer of
UBE3A expression. The methyl-binding protein MeCP2
binds to the methylated PWS-IC allele [25,31,47,48],
and MECP2 mutation has been shown to correspond
with reduced UBE3A and GABRB3 levels in human
brain [31]. Therefore, increased binding of MeCP2 to
highly methylated PWS-IC in brain may act as a positive
transcriptional regulator of UBE3A and, to a lesser
extent, GABRB3 in human cortex.
In contrast to UBE3A, GABRB3 exhibited no signifi-
cant change in the mean expression in the dup15q corti-
cal samples compared to controls. Instead, significant
variability in GABRB3 levels, as well as an interesting
bimodal separation in GABRB3 levels of the dup15q
samples, was observed in dup15q samples. This result is
similar to our findings in a prior study of two samples
with discordant GABRB3 levels [26], as well as the find-
ing of reduced GABRB3 levels in 56% of autism cortex
samples [22]. SNRPN levels were decreased overall in all
dup15q samples in this study, which deviates from our
previous study result from sample 7014 at a different
brain region, BA9, examined previously [26]. This unex-
pected result of reduced SNRPN in dup15q postmortem
cortex samples suggests that an increase in maternal
dosage of the region epigenetically affects transcription
of a paternally expressed gene, possibly in a tissue- or
region-specific manner. In contrast to UBE3A and
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methylation, SNRPN levels showed a negative correla-
tion with PWS-IC methylation. These results suggest
that although maternal methylation of the PWS-IC is
repressive to SNRPN expression, as expected, there
appears to be a long-range enhancing effect of PWS-IC
methylation on UBE3A and GABRB3. Homologous
chromosome pairing of maternal and paternal 15q11-
q13 alleles occurs in human lymphocytes, neuronal cells
and brain [23-25]. Both dup15q brain samples and a
neuronal cell culture model of dup15q in SH-SY5Y neu-
ronal cells showed significant disruption of homologous
pairing that corresponded to reduced SNRPN and lower
than expected GABRB3 levels [24,26].
Conclusions
This study, together with previous studies of dup15q
syndrome, shows that dup15q brain samples are epigen-
etically complex and that 15q11-q13 transcripts in brain
do not behave solely as predicted by copy number.
These findings should be important for understanding
ASD cases with other de novo copy number variations
on other chromosomes, in particular large duplications
[49]. The bimodal pattern of GABRB3 deficiencies seen
in these 8 dup15q samples may provide some insight
into the relationship between dup15q and seizures.
Maternal UPD PWS individuals have a higher incidence
of seizures than individuals with deletions [14], suggest-
ing that these people may also have epigenetically
induced GABRB3 deficiency. GABRB3 and UBE3A are
well-characterized candidate genes for ASD because
they are associated with normal brain development and
have been shown to be reduced in idiopathic autism,
Angelman syndrome and Rett syndrome [31]. Although
these results provide support for the hypothesis that
overexpression of the maternally expressed UBE3A gene
in the brain is the primary underlying cause of the ASD
phenotype in dup15q, the changes in GABRB3 and
SNRPN expression not predicted by copy number may
also influence the phenotypic variability observed in
ASD.
Additional material
Additional file 1: Primers used in this study. Primer sequences used
for quantitative RT-PCR and copy number analyses are provided.
Additional file 2: Ubiquitin ligase 3A (UBE3A) transcript levels are
significantly higher in duplication of 15q11-q13 (dup15q) copy
number samples than in control and autism brain tissues. Fold
change vs genotype for UBE3A levels in brain tissue.
Additional file 3: Correlation analyses of 15q11-q13 copy number
and transcript levels. This analysis was performed as explained in
Figure 5, except that only the duplication of 15q11-q13 (dup15q)
samples were correlated with copy number.
Additional file 4: Correlation analyses of imprinting center of the
Prader-Willi locus (PWS-IC) methylation and ubiquitin ligase 3A
(UBE3A) transcript levels. This analysis was performed as explained in
Figures 6a and 6b, except that only the controls or autism samples were
correlated with PWS-IC methylation.
Additional file 5: Correlation analyses of imprinting center of the
Prader-Willi locus (PWS-IC) and GABAA receptor b3( GABRB3)
transcript levels. This analysis was performed as explained in Figure 6c,
except that only the duplication of 15q11-q13 (dup15q), controls or
autism samples were correlated with PWS-IC methylation.
Additional file 6: Correlation analyses of imprinting center of the
Prader-Willi locus (PWS-IC) methylation and SNRPN transcript levels.
This analysis was performed as explained in Figure 6d, except that only
the duplication of 15q11-q13 (dup15q), controls or autism samples were
correlated with PWS-IC methylation.
Additional file 7: Distribution of ubiquitin ligase 3A (UBE3A) and
GABAA receptor b3 (GABRB3) protein levels in individual brain
samples by condition. Western blot analyses of protein levels were
performed as described in Figure 7 for UBE3A or GABRB3.
Additional file 8: Protein levels showed no significant association
with copy number. We found no significant relationship between
UBE3A or GABRB3 protein levels and copy number in all cases or in
duplication of 15q11-q13 (dup15q) only.
Additional file 9: Ubiquitin ligase 3A (UBE3A) protein levels did not
correlate with imprinting center of the Prader-Willi locus (PWS-IC)
methylation. In all cases, the positive trend between UBE3A protein
level and methylation was similar to transcript level and methylation;
however, it did not reach significance, nor did the other groups when
analyzed separately.
Additional file 10: GABAA receptor b3 (GABRB3) protein levels did
not correlate with imprinting center of the Prader-Willi locus (PWS-
IC) methylation. When all three groups were analyzed together or
separately, there was no correlation between percentage PWS-IC
methylation and GABRB3 protein levels.
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